Dewi Ratna Nur Hawati

Work History

PT FERRING PHARMACEUTICALS INDUSTRY

01.2022 - Current

Successfully launched the PENTASA portfolio, demonstrating a significant growth in 2024.
Strengthen FERRING's Gastro Franchise by driving the accelerated growth of GLYPRESSIN and PENTASA.
Collaborated with the team and successfully entered the public market (FORNAS and JKN) for the PENTASA portfolio in 2023.
Collaborated with third parties for co-promotion and exclusive distribution of products.
Managed full product lifecycle, from ideation through post-launch support, ensuring consistent quality control measures were in place.
Collaborated with sales, and support teams to launch products on time and within budget.

PT FERRING PHARMACEUTICALS INDUSTRY

05.2019 - 01.2022

Smoothly transition of Alliance Management
Support in GMP Certification of Garuda Project from authority. Production and GMP Certification received as per timeline
Successfully launch of of GLYPRESSIN in Indonesia Market.
Finalize comprehensive launch plan of PENTASA
Point of Contact (PIC) for distributor selection and ensuring alignment with the distributor.

FERRING PRIVATE LTD

03.2018 - 04.2019

Responsible to ensure Ferring Partnership with local pharmaceutical company as distributor able to achieve its objective.
Primarily Responsible for GARUDA PROJECT, a manufacturing establishment in Indonesia.
Communication and liaise with several stakeholder (Legal consultant, MOH, BPOM, Environmental Department, BKPM and OSS) for the purposes of manufacturing establishment.
Responsible also for Office Relocation,General administrative, Administrative, Financial record and HR.

FERRING PRIVATE LTD

05.2016 - 03.2018

Collaborated with a legal consultant to successfully ensure the timely establishment of Ferring's representative office in Indonesia.
Collaborated with GM in building company core team, General Administrative and Financial record.
Collaborated with regulatory teams to obtain new drug approvals and maintain product licenses.
Collaborate with partner during brand plan preparation to achieve grow in fertility franchise 10 %.
Execute Business Development Deal with new partner for Obstetrics portfolio and Minirin.
Served Patient needs by successfully performed importation with SAS Scheme for Minirin Nasal Spray. .

PT Aventis Pharma

10.2006 - 01.2008

Improved overall efficiency of the QA department through strategic planning and resource allocation.
Managed cross-functional teams to ensure seamless coordination between QA, development, and support departments.
Conducted root cause analysis on recurring defects, implementing corrective measures to prevent future occurrences.
Optimized test case coverage by identifying gaps in existing test plans and devising new strategies for comprehensive testing.